Ken Fisher
EW icon

Ken Fisher’s Edwards Lifesciences EW Stock Holding History

Ken Fisher’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Sell
132,199
-13,446
-9% -$1.11M ﹤0.01% 393
2025
Q4 		$12.4M Sell
145,645
-101,775
-41% -$8.35M ﹤0.01% 382
2025
Q3 		$19.2M Sell
247,420
-68,972
-22% -$5.39M 0.01% 329
2025
Q2 		$24.7M Sell
316,392
-9,784,074
-97% -$730M 0.01% 292
2025
Q1 		$732M Buy
10,100,466
+325,190
+3% +$23.3M 0.32% 85
2024
Q4 		$724M Buy
9,775,276
+696,965
+8% +$48.8M 0.29% 78
2024
Q3 		$599M Buy
9,078,311
+806,705
+10% +$58.6M 0.25% 89
2024
Q2 		$764M Buy
8,271,606
+644,728
+8% +$57.1M 0.33% 79
2024
Q1 		$729M Buy
7,626,878
+498,599
+7% +$41.9M 0.34% 79
2023
Q4 		$544M Sell
7,128,279
-186,188
-3% -$13M 0.29% 90
2023
Q3 		$507M Sell
7,314,467
-703,324
-9% -$56.5M 0.29% 95
2023
Q2 		$756M Buy
8,017,791
+198,252
+3% +$17.2M 0.42% 73
2023
Q1 		$647M Buy
7,819,539
+146,921
+2% +$11.5M 0.39% 82
2022
Q4 		$572M Buy
7,672,618
+133,880
+2% +$10.3M 0.39% 80
2022
Q3 		$623M Buy
7,538,738
+208,057
+3% +$20M 0.47% 66
2022
Q2 		$697M Buy
7,330,681
+227,736
+3% +$23.6M 0.49% 63
2022
Q1 		$836M Buy
7,102,945
+320,643
+5% +$36M 0.49% 63
2021
Q4 		$879M Buy
6,782,302
+357,605
+6% +$41.7M 0.49% 52
2021
Q3 		$727M Buy
6,424,697
+267,356
+4% +$30.5M 0.45% 64
2021
Q2 		$638M Buy
6,157,341
+334,627
+6% +$31.5M 0.4% 66
2021
Q1 		$487M Buy
5,822,714
+244,081
+4% +$20.6M 0.34% 74
2020
Q4 		$509M Buy
5,578,633
+386,233
+7% +$32M 0.38% 67
2020
Q3 		$414M Buy
5,192,400
+204,982
+4% +$16M 0.36% 64
2020
Q2 		$345M Buy
4,987,418
+923,309
+23% +$65.6M 0.34% 71
2020
Q1 		$256M Buy
4,064,109
+4,040,349
+17,005% +$291M 0.32% 72
2019
Q4 		$1.85M Sell
23,760
-4,038
-15% -$315K ﹤0.01% 502
2019
Q3 		$2.04M Buy
27,798
+6,423
+30% +$451K ﹤0.01% 532
2019
Q2 		$1.32M Buy
+21,375
New +$1.29M ﹤0.01% 584

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ken Fisher's EW Position: Q1 2026 in Review

Ken Fisher reduced its Edwards Lifesciences (EW) stake by 9.2% in Q1 2026, selling an estimated $1.11M and leaving 132,199 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Ken Fisher first reported a position in EW in Q2 2019 and has held it in 28 quarters since. The position peaked at $879M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Ken Fisher held 132,199 shares of Edwards Lifesciences worth $10.6M as of Q1 2026.
  • Ken Fisher sold 13,446 Edwards Lifesciences shares in Q1 2026, an estimated $1.11M.
  • Edwards Lifesciences made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #393 holding.
  • Ken Fisher first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 28 quarters since.
  • Ken Fisher's Edwards Lifesciences position peaked at $879M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.